Nanotechnology Now - Press Release: New Nanomaterial for regenerative medicines at SMi’s Pharmaceutical Nanotechnology conference

Home > Press > New Nanomaterial for regenerative medicines at SMi’s Pharmaceutical Nanotechnology conference

Abstract:
Nanotechnology is a multidisciplinary scientific field that is currently undergoing explosive development. Nano-enhanced medicines are opening new opportunities for therapeutic delivery and targeting technology

New Nanomaterial for regenerative medicines at SMi’s Pharmaceutical Nanotechnology conference

London, UK | Posted on March 27th, 2011

Join SMi at their inaugural case study driven conference that will address not only the latest scientific developments, but also the know-how required to successfully translate these discoveries and technologies into a commercially successful product.

Come and hear key presentations from the top 50 pharma companies that include:

The business case for nanotechnology
Thomas Keller, Director, Open Innovation, GlaxoSmithKline

Miniaturisation and modelling of beads milling
Mostafa Nakach, Head of Pharmaceutical Engineering Group, Sanofi-Aventis R&D

Investigation of chitosan nanoparticle formulations
Michael Keller, Senior Fellow, siRNA Project Leader, Technical Research and Development (TRD), Novartis Pharma

Enabling oncology drug development with nanotechnology
Henry Havel, Senior Research Fellow, Product Research and Development, Eli Lilly and company

Industry partnering opportunities, open innovation, one solution
Peter Luke, Senior Director, R&D Business Development, Worldwide Business Development, Pfizer

####

About SMi
Pharmaceutical Nanotechnology: Applications & Commercialisation is just one of the many conferences that are a part of the SMi Group portfolio.

The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk

For more information, please click here

Contacts:
Zain Philbey
+44 0 207 827 6722

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: